Global Mifepristone Market Growth 2023-2029

The report requires updating with new data and is sent in 48 hours after order is placed.

Mifepristone is a progestational and glucocorticoid hormone antagonist. Its inhibition of progesterone induces bleeding during the luteal phase and in early pregnancy by releasing endogenous prostaglandins from the endometrium or decidua.

LPI (LP Information)' newest research report, the “Mifepristone Industry Forecast” looks at past sales and reviews total world Mifepristone sales in 2022, providing a comprehensive analysis by region and market sector of projected Mifepristone sales for 2023 through 2029. With Mifepristone sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Mifepristone industry.

This Insight Report provides a comprehensive analysis of the global Mifepristone landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Mifepristone portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms' unique position in an accelerating global Mifepristone market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Mifepristone and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Mifepristone.

The global Mifepristone market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.

United States market for Mifepristone is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.

China market for Mifepristone is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.

Europe market for Mifepristone is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.

Global key Mifepristone players cover Merck Serono, Pfizer, GenBioPro, Linepharma International, Monsanto/Searle, Zhejiang Xianju Pharmaceutical, Hubei Gedian Renfu Pharmaceutical, Shanghai Xinhualian Pharmaceutical and Huarun Zizhu Pharmaceutical, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.

This report presents a comprehensive overview, market shares, and growth opportunities of Mifepristone market by product type, application, key manufacturers and key regions and countries.

Market Segmentation:

Segmentation by type

• Tablets
• (Soft) Capsule
• Other

Segmentation by application

• Anti-Early And Mid-Term Pregnancy Drugs (Abortifacients)
• Pregnant,
• Urged By The Check
• Intrauterine Induction Of Labor After Fetal Death
• Gynecologic Surgery
• Other

This report also splits the market by region:

• Americas
• United States
• Canada
• Mexico
• Brazil
• APAC
• China
• Japan
• Korea
• Southeast Asia
• India
• Australia
• Europe
• Germany
• France
• UK
• Italy
• Russia
• Middle East & Africa
• Egypt
• South Africa
• Israel
• Turkey
• GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.

• Merck Serono
• Pfizer
• GenBioPro
• Linepharma International
• Monsanto/Searle
• Zhejiang Xianju Pharmaceutical
• Hubei Gedian Renfu Pharmaceutical
• Shanghai Xinhualian Pharmaceutical
• Huarun Zizhu Pharmaceutical
• Guangzhou Longsheng Pharmaceutical
• Shenzhen Zifu Pharmaceutical

Key Questions Addressed in this Report

What is the 10-year outlook for the global Mifepristone market?

What factors are driving Mifepristone market growth, globally and by region?

Which technologies are poised for the fastest growth by market and region?

How do Mifepristone market opportunities vary by end market size?

How does Mifepristone break out type, application?

What are the influences of COVID-19 and Russia-Ukraine war?

LIST OF TABLES

Table 1. Mifepristone Annual Sales CAGR by Geographic Region (2018, 2022 & 2029) & ($ millions)
Table 2. Mifepristone Annual Sales CAGR by Country/Region (2018, 2022 & 2029) & ($ millions)
Table 3. Major Players of Tablets
Table 4. Major Players of (Soft) Capsule
Table 5. Major Players of Other
Table 6. Global Mifepristone Sales by Type (2018-2023) & (KG)
Table 7. Global Mifepristone Sales Market Share by Type (2018-2023)
Table 8. Global Mifepristone Revenue by Type (2018-2023) & ($ million)
Table 9. Global Mifepristone Revenue Market Share by Type (2018-2023)
Table 10. Global Mifepristone Sale Price by Type (2018-2023) & (US$/G)
Table 11. Global Mifepristone Sales by Application (2018-2023) & (KG)
Table 12. Global Mifepristone Sales Market Share by Application (2018-2023)
Table 13. Global Mifepristone Revenue by Application (2018-2023)
Table 14. Global Mifepristone Revenue Market Share by Application (2018-2023)
Table 15. Global Mifepristone Sale Price by Application (2018-2023) & (US$/G)
Table 16. Global Mifepristone Sales by Company (2018-2023) & (KG)
Table 17. Global Mifepristone Sales Market Share by Company (2018-2023)
Table 18. Global Mifepristone Revenue by Company (2018-2023) ($ Millions)
Table 19. Global Mifepristone Revenue Market Share by Company (2018-2023)
Table 20. Global Mifepristone Sale Price by Company (2018-2023) & (US$/G)
Table 21. Key Manufacturers Mifepristone Producing Area Distribution and Sales Area
Table 22. Players Mifepristone Products Offered
Table 23. Mifepristone Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
Table 24. New Products and Potential Entrants
Table 25. Mergers & Acquisitions, Expansion
Table 26. Global Mifepristone Sales by Geographic Region (2018-2023) & (KG)
Table 27. Global Mifepristone Sales Market Share Geographic Region (2018-2023)
Table 28. Global Mifepristone Revenue by Geographic Region (2018-2023) & ($ millions)
Table 29. Global Mifepristone Revenue Market Share by Geographic Region (2018-2023)
Table 30. Global Mifepristone Sales by Country/Region (2018-2023) & (KG)
Table 31. Global Mifepristone Sales Market Share by Country/Region (2018-2023)
Table 32. Global Mifepristone Revenue by Country/Region (2018-2023) & ($ millions)
Table 33. Global Mifepristone Revenue Market Share by Country/Region (2018-2023)
Table 34. Americas Mifepristone Sales by Country (2018-2023) & (KG)
Table 35. Americas Mifepristone Sales Market Share by Country (2018-2023)
Table 36. Americas Mifepristone Revenue by Country (2018-2023) & ($ Millions)
Table 37. Americas Mifepristone Revenue Market Share by Country (2018-2023)
Table 38. Americas Mifepristone Sales by Type (2018-2023) & (KG)
Table 39. Americas Mifepristone Sales by Application (2018-2023) & (KG)
Table 40. APAC Mifepristone Sales by Region (2018-2023) & (KG)
Table 41. APAC Mifepristone Sales Market Share by Region (2018-2023)
Table 42. APAC Mifepristone Revenue by Region (2018-2023) & ($ Millions)
Table 43. APAC Mifepristone Revenue Market Share by Region (2018-2023)
Table 44. APAC Mifepristone Sales by Type (2018-2023) & (KG)
Table 45. APAC Mifepristone Sales by Application (2018-2023) & (KG)
Table 46. Europe Mifepristone Sales by Country (2018-2023) & (KG)
Table 47. Europe Mifepristone Sales Market Share by Country (2018-2023)
Table 48. Europe Mifepristone Revenue by Country (2018-2023) & ($ Millions)
Table 49. Europe Mifepristone Revenue Market Share by Country (2018-2023)
Table 50. Europe Mifepristone Sales by Type (2018-2023) & (KG)
Table 51. Europe Mifepristone Sales by Application (2018-2023) & (KG)
Table 52. Middle East & Africa Mifepristone Sales by Country (2018-2023) & (KG)
Table 53. Middle East & Africa Mifepristone Sales Market Share by Country (2018-2023)
Table 54. Middle East & Africa Mifepristone Revenue by Country (2018-2023) & ($ Millions)
Table 55. Middle East & Africa Mifepristone Revenue Market Share by Country (2018-2023)
Table 56. Middle East & Africa Mifepristone Sales by Type (2018-2023) & (KG)
Table 57. Middle East & Africa Mifepristone Sales by Application (2018-2023) & (KG)
Table 58. Key Market Drivers & Growth Opportunities of Mifepristone
Table 59. Key Market Challenges & Risks of Mifepristone
Table 60. Key Industry Trends of Mifepristone
Table 61. Mifepristone Raw Material
Table 62. Key Suppliers of Raw Materials
Table 63. Mifepristone Distributors List
Table 64. Mifepristone Customer List
Table 65. Global Mifepristone Sales Forecast by Region (2024-2029) & (KG)
Table 66. Global Mifepristone Revenue Forecast by Region (2024-2029) & ($ millions)
Table 67. Americas Mifepristone Sales Forecast by Country (2024-2029) & (KG)
Table 68. Americas Mifepristone Revenue Forecast by Country (2024-2029) & ($ millions)
Table 69. APAC Mifepristone Sales Forecast by Region (2024-2029) & (KG)
Table 70. APAC Mifepristone Revenue Forecast by Region (2024-2029) & ($ millions)
Table 71. Europe Mifepristone Sales Forecast by Country (2024-2029) & (KG)
Table 72. Europe Mifepristone Revenue Forecast by Country (2024-2029) & ($ millions)
Table 73. Middle East & Africa Mifepristone Sales Forecast by Country (2024-2029) & (KG)
Table 74. Middle East & Africa Mifepristone Revenue Forecast by Country (2024-2029) & ($ millions)
Table 75. Global Mifepristone Sales Forecast by Type (2024-2029) & (KG)
Table 76. Global Mifepristone Revenue Forecast by Type (2024-2029) & ($ Millions)
Table 77. Global Mifepristone Sales Forecast by Application (2024-2029) & (KG)
Table 78. Global Mifepristone Revenue Forecast by Application (2024-2029) & ($ Millions)
Table 79. Merck Serono Basic Information, Mifepristone Manufacturing Base, Sales Area and Its Competitors
Table 80. Merck Serono Mifepristone Product Portfolios and Specifications
Table 81. Merck Serono Mifepristone Sales (KG), Revenue ($ Million), Price (US$/G) and Gross Margin (2018-2023)
Table 82. Merck Serono Main Business
Table 83. Merck Serono Latest Developments
Table 84. Pfizer Basic Information, Mifepristone Manufacturing Base, Sales Area and Its Competitors
Table 85. Pfizer Mifepristone Product Portfolios and Specifications
Table 86. Pfizer Mifepristone Sales (KG), Revenue ($ Million), Price (US$/G) and Gross Margin (2018-2023)
Table 87. Pfizer Main Business
Table 88. Pfizer Latest Developments
Table 89. GenBioPro Basic Information, Mifepristone Manufacturing Base, Sales Area and Its Competitors
Table 90. GenBioPro Mifepristone Product Portfolios and Specifications
Table 91. GenBioPro Mifepristone Sales (KG), Revenue ($ Million), Price (US$/G) and Gross Margin (2018-2023)
Table 92. GenBioPro Main Business
Table 93. GenBioPro Latest Developments
Table 94. Linepharma International Basic Information, Mifepristone Manufacturing Base, Sales Area and Its Competitors
Table 95. Linepharma International Mifepristone Product Portfolios and Specifications
Table 96. Linepharma International Mifepristone Sales (KG), Revenue ($ Million), Price (US$/G) and Gross Margin (2018-2023)
Table 97. Linepharma International Main Business
Table 98. Linepharma International Latest Developments
Table 99. Monsanto/Searle Basic Information, Mifepristone Manufacturing Base, Sales Area and Its Competitors
Table 100. Monsanto/Searle Mifepristone Product Portfolios and Specifications
Table 101. Monsanto/Searle Mifepristone Sales (KG), Revenue ($ Million), Price (US$/G) and Gross Margin (2018-2023)
Table 102. Monsanto/Searle Main Business
Table 103. Monsanto/Searle Latest Developments
Table 104. Zhejiang Xianju Pharmaceutical Basic Information, Mifepristone Manufacturing Base, Sales Area and Its Competitors
Table 105. Zhejiang Xianju Pharmaceutical Mifepristone Product Portfolios and Specifications
Table 106. Zhejiang Xianju Pharmaceutical Mifepristone Sales (KG), Revenue ($ Million), Price (US$/G) and Gross Margin (2018-2023)
Table 107. Zhejiang Xianju Pharmaceutical Main Business
Table 108. Zhejiang Xianju Pharmaceutical Latest Developments
Table 109. Hubei Gedian Renfu Pharmaceutical Basic Information, Mifepristone Manufacturing Base, Sales Area and Its Competitors
Table 110. Hubei Gedian Renfu Pharmaceutical Mifepristone Product Portfolios and Specifications
Table 111. Hubei Gedian Renfu Pharmaceutical Mifepristone Sales (KG), Revenue ($ Million), Price (US$/G) and Gross Margin (2018-2023)
Table 112. Hubei Gedian Renfu Pharmaceutical Main Business
Table 113. Hubei Gedian Renfu Pharmaceutical Latest Developments
Table 114. Shanghai Xinhualian Pharmaceutical Basic Information, Mifepristone Manufacturing Base, Sales Area and Its Competitors
Table 115. Shanghai Xinhualian Pharmaceutical Mifepristone Product Portfolios and Specifications
Table 116. Shanghai Xinhualian Pharmaceutical Mifepristone Sales (KG), Revenue ($ Million), Price (US$/G) and Gross Margin (2018-2023)
Table 117. Shanghai Xinhualian Pharmaceutical Main Business
Table 118. Shanghai Xinhualian Pharmaceutical Latest Developments
Table 119. Huarun Zizhu Pharmaceutical Basic Information, Mifepristone Manufacturing Base, Sales Area and Its Competitors
Table 120. Huarun Zizhu Pharmaceutical Mifepristone Product Portfolios and Specifications
Table 121. Huarun Zizhu Pharmaceutical Mifepristone Sales (KG), Revenue ($ Million), Price (US$/G) and Gross Margin (2018-2023)
Table 122. Huarun Zizhu Pharmaceutical Main Business
Table 123. Huarun Zizhu Pharmaceutical Latest Developments
Table 124. Guangzhou Longsheng Pharmaceutical Basic Information, Mifepristone Manufacturing Base, Sales Area and Its Competitors
Table 125. Guangzhou Longsheng Pharmaceutical Mifepristone Product Portfolios and Specifications
Table 126. Guangzhou Longsheng Pharmaceutical Mifepristone Sales (KG), Revenue ($ Million), Price (US$/G) and Gross Margin (2018-2023)
Table 127. Guangzhou Longsheng Pharmaceutical Main Business
Table 128. Guangzhou Longsheng Pharmaceutical Latest Developments
Table 129. Shenzhen Zifu Pharmaceutical Basic Information, Mifepristone Manufacturing Base, Sales Area and Its Competitors
Table 130. Shenzhen Zifu Pharmaceutical Mifepristone Product Portfolios and Specifications
Table 131. Shenzhen Zifu Pharmaceutical Mifepristone Sales (KG), Revenue ($ Million), Price (US$/G) and Gross Margin (2018-2023)
Table 132. Shenzhen Zifu Pharmaceutical Main Business
Table 133. Shenzhen Zifu Pharmaceutical Latest Developments

LIST OF FIGURES

Figure 1. Picture of Mifepristone
Figure 2. Mifepristone Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Mifepristone Sales Growth Rate 2018-2029 (KG)
Figure 7. Global Mifepristone Revenue Growth Rate 2018-2029 ($ Millions)
Figure 8. Mifepristone Sales by Region (2018, 2022 & 2029) & ($ Millions)
Figure 9. Product Picture of Tablets
Figure 10. Product Picture of (Soft) Capsule
Figure 11. Product Picture of Other
Figure 12. Global Mifepristone Sales Market Share by Type in 2022
Figure 13. Global Mifepristone Revenue Market Share by Type (2018-2023)
Figure 14. Mifepristone Consumed in Anti-Early And Mid-Term Pregnancy Drugs (Abortifacients)
Figure 15. Global Mifepristone Market: Anti-Early And Mid-Term Pregnancy Drugs (Abortifacients) (2018-2023) & (KG)
Figure 16. Mifepristone Consumed in Pregnant,
Figure 17. Global Mifepristone Market: Pregnant, (2018-2023) & (KG)
Figure 18. Mifepristone Consumed in Urged By The Check
Figure 19. Global Mifepristone Market: Urged By The Check (2018-2023) & (KG)
Figure 20. Mifepristone Consumed in Intrauterine Induction Of Labor After Fetal Death
Figure 21. Global Mifepristone Market: Intrauterine Induction Of Labor After Fetal Death (2018-2023) & (KG)
Figure 22. Mifepristone Consumed in Gynecologic Surgery
Figure 23. Global Mifepristone Market: Gynecologic Surgery (2018-2023) & (KG)
Figure 24. Mifepristone Consumed in Other
Figure 25. Global Mifepristone Market: Other (2018-2023) & (KG)
Figure 26. Global Mifepristone Sales Market Share by Application (2022)
Figure 27. Global Mifepristone Revenue Market Share by Application in 2022
Figure 28. Mifepristone Sales Market by Company in 2022 (KG)
Figure 29. Global Mifepristone Sales Market Share by Company in 2022
Figure 30. Mifepristone Revenue Market by Company in 2022 ($ Million)
Figure 31. Global Mifepristone Revenue Market Share by Company in 2022
Figure 32. Global Mifepristone Sales Market Share by Geographic Region (2018-2023)
Figure 33. Global Mifepristone Revenue Market Share by Geographic Region in 2022
Figure 34. Americas Mifepristone Sales 2018-2023 (KG)
Figure 35. Americas Mifepristone Revenue 2018-2023 ($ Millions)
Figure 36. APAC Mifepristone Sales 2018-2023 (KG)
Figure 37. APAC Mifepristone Revenue 2018-2023 ($ Millions)
Figure 38. Europe Mifepristone Sales 2018-2023 (KG)
Figure 39. Europe Mifepristone Revenue 2018-2023 ($ Millions)
Figure 40. Middle East & Africa Mifepristone Sales 2018-2023 (KG)
Figure 41. Middle East & Africa Mifepristone Revenue 2018-2023 ($ Millions)
Figure 42. Americas Mifepristone Sales Market Share by Country in 2022
Figure 43. Americas Mifepristone Revenue Market Share by Country in 2022
Figure 44. Americas Mifepristone Sales Market Share by Type (2018-2023)
Figure 45. Americas Mifepristone Sales Market Share by Application (2018-2023)
Figure 46. United States Mifepristone Revenue Growth 2018-2023 ($ Millions)
Figure 47. Canada Mifepristone Revenue Growth 2018-2023 ($ Millions)
Figure 48. Mexico Mifepristone Revenue Growth 2018-2023 ($ Millions)
Figure 49. Brazil Mifepristone Revenue Growth 2018-2023 ($ Millions)
Figure 50. APAC Mifepristone Sales Market Share by Region in 2022
Figure 51. APAC Mifepristone Revenue Market Share by Regions in 2022
Figure 52. APAC Mifepristone Sales Market Share by Type (2018-2023)
Figure 53. APAC Mifepristone Sales Market Share by Application (2018-2023)
Figure 54. China Mifepristone Revenue Growth 2018-2023 ($ Millions)
Figure 55. Japan Mifepristone Revenue Growth 2018-2023 ($ Millions)
Figure 56. South Korea Mifepristone Revenue Growth 2018-2023 ($ Millions)
Figure 57. Southeast Asia Mifepristone Revenue Growth 2018-2023 ($ Millions)
Figure 58. India Mifepristone Revenue Growth 2018-2023 ($ Millions)
Figure 59. Australia Mifepristone Revenue Growth 2018-2023 ($ Millions)
Figure 60. China Taiwan Mifepristone Revenue Growth 2018-2023 ($ Millions)
Figure 61. Europe Mifepristone Sales Market Share by Country in 2022
Figure 62. Europe Mifepristone Revenue Market Share by Country in 2022
Figure 63. Europe Mifepristone Sales Market Share by Type (2018-2023)
Figure 64. Europe Mifepristone Sales Market Share by Application (2018-2023)
Figure 65. Germany Mifepristone Revenue Growth 2018-2023 ($ Millions)
Figure 66. France Mifepristone Revenue Growth 2018-2023 ($ Millions)
Figure 67. UK Mifepristone Revenue Growth 2018-2023 ($ Millions)
Figure 68. Italy Mifepristone Revenue Growth 2018-2023 ($ Millions)
Figure 69. Russia Mifepristone Revenue Growth 2018-2023 ($ Millions)
Figure 70. Middle East & Africa Mifepristone Sales Market Share by Country in 2022
Figure 71. Middle East & Africa Mifepristone Revenue Market Share by Country in 2022
Figure 72. Middle East & Africa Mifepristone Sales Market Share by Type (2018-2023)
Figure 73. Middle East & Africa Mifepristone Sales Market Share by Application (2018-2023)
Figure 74. Egypt Mifepristone Revenue Growth 2018-2023 ($ Millions)
Figure 75. South Africa Mifepristone Revenue Growth 2018-2023 ($ Millions)
Figure 76. Israel Mifepristone Revenue Growth 2018-2023 ($ Millions)
Figure 77. Turkey Mifepristone Revenue Growth 2018-2023 ($ Millions)
Figure 78. GCC Country Mifepristone Revenue Growth 2018-2023 ($ Millions)
Figure 79. Manufacturing Cost Structure Analysis of Mifepristone in 2022
Figure 80. Manufacturing Process Analysis of Mifepristone
Figure 81. Industry Chain Structure of Mifepristone
Figure 82. Channels of Distribution
Figure 83. Global Mifepristone Sales Market Forecast by Region (2024-2029)
Figure 84. Global Mifepristone Revenue Market Share Forecast by Region (2024-2029)
Figure 85. Global Mifepristone Sales Market Share Forecast by Type (2024-2029)
Figure 86. Global Mifepristone Revenue Market Share Forecast by Type (2024-2029)
Figure 87. Global Mifepristone Sales Market Share Forecast by Application (2024-2029)
Figure 88. Global Mifepristone Revenue Market Share Forecast by Application (2024-2029)